David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$549M |
| 2 |
CVS Health
CVS
|
+$537M |
| 3 |
Meta Platforms (Facebook)
META
|
+$515M |
| 4 |
McDonald's
MCD
|
+$386M |
| 5 |
Home Depot
HD
|
+$308M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Booking.com
BKNG
|
+$475M |
| 2 |
YHOO
Yahoo Inc
YHOO
|
+$442M |
| 3 |
AGN
Allergan plc
AGN
|
+$435M |
| 4 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$369M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$330M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 11.73% |
| 2 | Technology | 10.93% |
| 3 | Consumer Discretionary | 10.32% |
| 4 | Financials | 9.88% |
| 5 | Communication Services | 7.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SCTY
2976
DELISTED
SolarCity Corporation
SCTY
| $317K | ﹤0.01% |
13,240
-3,767
| -22% | -$92.8K |
|
|
PSG
2977
DELISTED
Performance Sports Group Ltd.
PSG
| $316K | ﹤0.01% |
105,173
-52,127
| -33% | -$172K |
|
2978
Supernus Pharmaceuticals
SUPN
$2.62B
| $315K | ﹤0.01% |
15,473
-6,537
| -30% | -$116K |
|
2979
Central Pacific Financial
CPF
$972M
| $311K | ﹤0.01% |
13,196
+1,377
| +12% | +$31.4K |
|
2980
PUT
Golar LNG
GLNG
$5.25B
| $310K | ﹤0.01% |
20,000
-10,000
| -33% | -$178K |
|
|
SUP
2981
DELISTED
Superior Industries International
SUP
| $309K | ﹤0.01% |
11,543
-4,242
| -27% | -$109K |
|
2982
Xcel Energy
XEL
$48.3B
| $308K | ﹤0.01% |
+6,877
| New | +$285K |
|
|
MXPT
2983
DELISTED
MaxPoint Interactive, Inc.
MXPT
| $308K | ﹤0.01% |
28,503
+449
| +2% | +$4.04K |
|
2984
Columbia Banking Systems
COLB
$8.67B
| $306K | ﹤0.01% |
10,908
-23,989
| -69% | -$704K |
|
|
FWP
2985
DELISTED
Forward Pharma A/S American Depositary Shares
FWP
| $306K | ﹤0.01% |
2,410
-72
| -3% | -$9.72K |
|
|
INFI
2986
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $305K | ﹤0.01% |
228,615
-143,841
| -39% | -$673K |
|
|
CRR
2987
DELISTED
Carbo Ceramics Inc.
CRR
| $305K | ﹤0.01% |
23,304
-229,820
| -91% | -$3.1M |
|
2988
Scholastic
SCHL
$760M
| $304K | ﹤0.01% |
7,682
-972
| -11% | -$36.6K |
|
2989
PUT
Nabors Industries
NBR
$1.31B
| $302K | ﹤0.01% |
600
| – | – |
|
2990
DXP Enterprises
DXPE
$2.9B
| $300K | ﹤0.01% |
20,090
-31,177
| -61% | -$525K |
|
2991
Lee Enterprises
LEE
$183M
| $299K | ﹤0.01% |
15,648
-650
| -4% | -$12.8K |
|
|
SGYP
2992
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
| $298K | ﹤0.01% |
+78,475
| New | +$266K |
|
|
MSB
2993
Mesabi Trust
MSB
$305M
| $297K | ﹤0.01% |
27,622
-13,573
| -33% | -$123K |
|
2994
Hawkins
HWKN
$2.46B
| $296K | ﹤0.01% |
+13,626
| New | +$274K |
|
|
LUMO
2995
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $296K | ﹤0.01% |
2,920
-591
| -17% | -$73.3K |
|
|
KLXI
2996
DELISTED
KLX Inc.
KLXI
| $296K | ﹤0.01% |
11,343
-21,778
| -66% | -$599K |
|
|
YDKN
2997
DELISTED
Yadkin Financial Corporation
YDKN
| $296K | ﹤0.01% |
+11,785
| New | +$295K |
|
2998
HSBC
HSBC
$357B
| $295K | ﹤0.01% |
10,586
-21,662
| -67% | -$613K |
|
2999
Celldex Therapeutics
CLDX
$3.19B
| $292K | ﹤0.01% |
+4,429
| New | +$281K |
|
|
MRIN
3000
DELISTED
Marin Software
MRIN
| $292K | ﹤0.01% |
2,954
-1,456
| -33% | -$155K |
|
Similar funds
David Shaw's Q2 2016 Portfolio in Review
As of Q2 2016, David Shaw held 3,766 positions worth $54.2B, down 2.7% from $55.7B the previous quarter. Its ten largest holdings account for 9.2% of the portfolio.
David Shaw withdrew a net $2.46B in Q2 2016, closing 445 positions and reducing 1,324 holdings. Its most notable exit was TIME WARNER CABLE INC NEW COM STK, an estimated $369M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 12% of assets, down from 14% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, David Shaw opened a new position in Liberty Media Corporation Series C Liberty SiriusXM Common Stock worth $198M.
- David Shaw's largest Q2 2016 buy was Liberty Media Corporation Series C Liberty SiriusXM Common Stock: 8,430,023 shares worth $198M.
- David Shaw added most to Amazon in Q2 2016, an estimated $549M increase.
- David Shaw's biggest Q2 2016 reduction was Booking.com, cutting an estimated $475M.
- David Shaw fully exited TIME WARNER CABLE INC NEW COM STK in Q2 2016, selling an estimated $369M.
- David Shaw's ten largest holdings make up 9.2% of its $54.2B portfolio in Q2 2016.
- David Shaw opened 402 new positions and closed 445 in Q2 2016.
- David Shaw's portfolio value fell 2.7% quarter-over-quarter to $54.2B.
Based on D.E. Shaw & Co's 13F filing for Q2 2016, filed 15 Aug 2016.